CoreWeave’s CEO has characterized the proposed $9 billion acquisition of Core Scientific as a “nice to have” rather than essential. Shareholder resistance continues to mount, with a key proxy advisor recommending against the deal ahead of the October 30 vote.
Deal Faces Mounting Opposition
CoreWeave CEO Michael Intrator has reportedly described the company’s proposed acquisition of Core Scientific as non-essential, stating the $9 billion all-stock deal represents a “nice to have” rather than a necessity for the AI cloud provider. This characterization comes as shareholder opposition to the acquisition intensifies, with a crucial vote scheduled for October 30 that could determine the deal’s fate.